 VALSARFEC D
|
Fecofar
|
| valsartán+hidroclorotiazida |
Antihipertensivo |
| 160/12.5 mg comp.x 30 | $32.510,67 | (30/07/26) |
| PAMI |
|
| AF $15.269,48 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.399,94 AF $13.110,73 |
|
|
|
|
| 160/25 mg comp.x 30 | $37.766,21 | (30/07/26) |
| PAMI |
|
| AF $16.679,65 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $24.255,32 AF $13.510,89 |
|
|
|
|
| 80/12.5 mg comp.x 30 | $28.005,93 | (30/07/26) |
| PAMI |
|
| AF $14.002,97 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $17.759,00 AF $10.246,93 |
|
|
|
|
| 80/12.5 mg comp.x 28 | $26.010,14 | (30/07/26) |
|
|
|
| 160/12.5 mg comp.x 28 | $30.193,82 | (30/07/26) |
| PAMI |
|
| AF $15.096,91 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.767,21 AF $14.426,61 |
|
|
|
|
| 160/25mg comp.x 28 | $35.074,86 | (30/07/26) |
| PAMI |
|
| AF $17.537,43 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.767,21 AF $19.307,65 |
|
|
|
|
| |
